Nasdaq
$7.35▲ 0.00%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $2.72BShares out 3.700M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
31- 9.21Pre-market26.09.21 22:0015-12GOther#●●●
AtaiBeckley Inc.
AtaiBeckley Inc. completed its merger with Albali Acquisition Corporation, a subsidiary of Eli Lilly and Company, on September 11, 2026. As the company became a wholly owned subsidiary of Eli Lilly, it has terminated its registration and reporting obligations under the Securities Exchange Act.…more
$7.35+0.00%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 9.18Overnight26.09.17 08:32filedS-8 POSOffering
AtaiBeckley Inc.
AtaiBeckley Inc. completed its merger with Eli Lilly and Company on September 11, 2026, becoming a wholly owned subsidiary of the parent company. Consequently, the company has terminated all offerings under its previous S-8 registration statements and deregistered all remaining unsold shares.…more
$7.35+0.00%vs prev closeView filingShare - 9.16Regular26.09.17 01:05S-8 POSOffering
AtaiBeckley Inc.
AtaiBeckley Inc. has terminated the effectiveness of its S-8 registration statements and deregistered all unsold shares following the completion of its merger with Eli Lilly and Company on September 11, 2026. The company has become a wholly owned subsidiary of Eli Lilly, and all offerings and sales of securities under these registration statements have been terminated.…more
$7.35+0.00%vs prev closeView filingShare
30 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 8.31After-hours26.09.01 05:42Bullish#●●●#●●●
AtaiBeckley-Eli Lilly Merger Clears Key Antitrust Reviews
The merger between AtaiBeckley and Eli Lilly is progressing as it has cleared antitrust reviews in the U.S. and the U.K. With the Australian regulatory review expected to conclude in early September, the acquisition remains on track.…more
$7.35+0.00%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga
- 8.18Regular26.08.19 02:35
●●●●●●●● ●●●●● ●●●●●●
Former President Trump stated that the University of Miami has shared its 1994 Ibogaine investigational new drug application with the government. This disclosure is expected to help accelerate the development of the substance as a medical treatment in the U.S.…more
$7.35+0.00%vs prev closeShareBenzinga
1 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report